Drug Shortage Report for APO-RIVASTIGMINE
| Report ID | 20900 |
| Drug Identification Number | 02336715 |
| Brand name | APO-RIVASTIGMINE |
| Common or Proper name | RIVASTIGMINE |
| Company Name | APOTEX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | RIVASTIGMINE |
| Strength(s) | 1.5MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL |
| Packaging size | 100 BTL |
| ATC code | N06DA |
| ATC description | ANTI-DEMENTIA DRUGS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2017-10-20 |
| Actual start date | 2017-10-16 |
| Estimated end date | 2019-10-18 |
| Actual end date | 2019-10-11 |
| Shortage status | Resolved |
| Updated date | 2019-10-15 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
| Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v18 | 2018-07-04 | French | Compare |
| v17 | 2018-07-04 | English | Compare |
| v16 | 2018-06-11 | French | Compare |
| v15 | 2018-06-11 | English | Compare |
| v14 | 2018-04-16 | French | Compare |
| v13 | 2018-04-16 | English | Compare |
| v12 | 2018-03-26 | French | Compare |
| v11 | 2018-03-26 | English | Compare |
| v10 | 2018-02-12 | French | Compare |
| v9 | 2018-02-12 | English | Compare |
| v8 | 2018-01-31 | French | Compare |
| v7 | 2018-01-31 | English | Compare |
| v6 | 2018-01-08 | French | Compare |
| v5 | 2018-01-08 | English | Compare |
| v4 | 2017-10-18 | French | Compare |
| v3 | 2017-10-18 | English | Compare |
| v2 | 2017-09-04 | French | Compare |
| v1 | 2017-09-04 | English | Compare |